Ibrutinib Is Effective in the Treatment of Autoimmune Haemolytic Anaemia in Mantle Cell Lymphoma

Publisher： Karger

E-ISSN： 1662-6575|10|1|127-129

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.10, Iss.1, 2017-01, pp. : 127-129

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ibrutinib is an effective treatment of autoimmune haemolytic anaemia in chronic lymphocytic leukaemia

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 5, 2015-09 ,pp. : 734-736

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rituximab in the treatment of autoimmune haemolytic anaemia

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 79, Iss. 5, 2015-05 ,pp. : 709-719

John Wiley & Sons Inc

Access to resources Recommend Favorite

Eryptosis in autoimmune haemolytic anaemia

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 1, 2018-01 ,pp. : 36-44

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ibrutinib‐associated lymphocytosis corresponds to bone marrow involvement in mantle cell lymphoma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 1, 2015-07 ,pp. : 131-134

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mesenteric Panniculitis Presenting with Autoimmune Haemolytic Anaemia

By  

Acta Haematologica, Vol. 107, Iss. 1, 2002-01 ,pp. : 35-37

Karger

Access to resources Recommend Favorite